Shares in Irish drug company Alkermes jumped over 10 per cent yesterday after it announced plans to seek US marketing approval for its experimental schizophrenia drug. The move came as the company announced positive results from a late-stage trial for the injectable drug, aripiprazole lauroxil. The drug is a long-acting atypical antipsychotic, a class of drugs with fewer...
↧